TORONTO, August 21, 2026, 13:05 EDT
- DNN climbed 12.26% to $3.52 as of 12:33 p.m. EDT.
- The action increased equity value by approximately $344 million.
- The increase was nearly equivalent to the $345 million principal of Denison’s note.
Denison Mines Corp. (NYSEAMERICAN:DNN) gained nearly $344 million in market capitalization on Friday, an increase close to the sum raised through its convertible-note offering. Shares climbed 12.26% to $3.52 as of 12:33 p.m. EDT.
The comparison highlights the speed at which sentiment on uranium can revalue a developer. Denison’s 905.22 million shares climbed by $0.38 apiece, reflecting a $343.98 million rise—just $1.02 million shy of the $345 million note principal.
| Market snapshot | Value | Investor read |
|---|---|---|
| DNN price | $3.52 | 12:33 p.m. EDT, Aug. 21 |
| Day change | +12.26% | Up $0.38 each share |
| Market capitalization | $3.20 billion | Development-stage assessed value |
| Volume | 28.40 million | 18.2% higher vs. 24.03 million average |
| 52-week range | $1.96–$4.43 | 20.5% off the highest point |
Denison was at the forefront of a broad advance in uranium stocks. Cameco Corp. NYSE:CCJ climbed 5.74%, while NexGen Energy Ltd. NYSE:NXE added 4.90%. The average gain for the four peers stood at 7.83%, putting Denison 4.43 percentage points above that mark.
| Uranium equity | Price | Intraday change |
|---|---|---|
| Denison Mines (NYSEAMERICAN:DNN) | $3.52 | up 12.26% |
| Uranium Energy Corp. (NYSEAMERICAN:UEC) | $12.39 | up 11.12% |
| Energy Fuels Inc. NYSEAMERICAN:UUUU | $15.23 | up 9.57% |
| Cameco NYSE:CCJ | $101.08 | up 5.74% |
| NexGen Energy NYSE:NXE | $10.71 | up 4.90% |
The sector continues to show strength. NexGen aims to raise roughly $1 billion for its Rook I project, as Denison advances construction of Phoenix. Canaccord forecasts uranium demand will be three times higher by 2035 compared to 2025.
Denison completed the notes offering in August 2025. The notes have a 4.25% coupon and generated approximately $333 million in net proceeds. The initial conversion price stands at $2.92. With a capped-call structure, the effective protection level increases to $4.32.
| Financing comparison | Amount or level | Relation to $3.52 share price |
|---|---|---|
| Friday’s increase in market value | $343.98 million | 99.7% of the convertible principal |
| Principal amount of convertible note | $345.00 million | $1.02 million more than the market value gain |
| Net proceeds from note | About $333 million | Amount remaining after deducting fees |
| First conversion price | $2.92 | Share price 20.5% above this level |
| Capped call strike price | $4.32 | Share price 18.5% below this point |
The stock has surpassed the initial conversion threshold but is still trading under the capped-call price. This difference is significant, as the overlay aims to limit dilution risk as the share price climbs.
Construction forms the primary benchmark. Denison said over 20% of site civil works were complete by late July. Civil subgrade activities at the process plant and wellfield approached completion. Installation of the phase-one freeze-wall was underway.
The funding arrangement features physical uranium. In the second quarter, Denison sold 750,000 pounds, generating $91.6 million Canadian. The firm posted a realized gain of $64.1 million, equal to 233%. Chief Executive David Cates said, “These transactions provide meaningful funding for Phoenix without dilution to our shareholders.” Denison Q2 results
| Phoenix and funding checkpoint | Verified figure | Status |
|---|---|---|
| Revised estimate for initial capital | C$600 million | Class 2 estimate |
| Site civil construction overall | Above 20% | Expected finished by late July |
| Plant and wellfield subgrade preparation | Close to 100% | Finished |
| Capacity at temporary camp | Up to nearly 400 people | Commissioned |
| Second quarter uranium sales | 750,000 pounds | US$66.9 million in gross proceeds |
| Aim for first production | Mid-2028 | Company timeline |
Analysts hold a positive outlook, but note that targets represent projections. According to an S&P Global poll from July 13, the average price target for DNN is $4.99—41.8% higher than the last quoted price on Friday. Coverage from Canadian analysts is also largely favourable.
| Analyst recommendation | Rating | Target | Date |
|---|---|---|---|
| S&P Global consensus, 14 analysts | Strong Buy | US$4.99 average | July 13, 2026 |
| Royal Bank of Canada | Outperform | C$6.00 | July 14, 2026 |
| National Bank Financial | Outperform | C$6.50 | April 17, 2026 |
| TD Securities | Buy | C$6.50 | March 12, 2026 |
The next proof point will be project execution. In August, crews will pour concrete for the process plant and substation foundations. Investors are also monitoring Denison’s pending uranium sales and expenditures relative to the C$600 million capital projection.
Risks: Phoenix continues to encounter risks related to construction, expenses, groundwater and commissioning. Uranium prices may decline rapidly. Should prices go above the capped-call threshold, dilution economics could gain significance.


